TherapeuticsMD

ANNOVERA

Manufacturer:

TherapeuticsMD

Annovera HCPCS:

J7294

HCPCS Code Descriptor:

Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each

Category:

J Code

Annovera NDCs:

50261-0313-01

Primary Type:

Contraceptive/ Long Acting Reversible

Generic/Specialty Status:

Single-Source

Route of Administration:

Vaginal

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Annovera:

ANNOVERA is a Contraceptive/ Long Acting Reversible drug manufactured by TherapeuticsMD and administered via the Vaginal route of administration. The J Code: J7294 is aligned to the drug ANNOVERA.

ACCESS PRICING AND MORE BY REGISTERING

J7294 Added Date:

October 1, 2021

J7294 Effective Date:

October 1, 2021

J7294 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Annovera billing and coding information.
Annovera patient assistance information can be found through The ANNOVERA PATIENT SAVINGS PROGRAM at the URL: https://www.annoverahcp.com/savings-and-support/
ANNOVERA prescribing information can be found at the link below:
Information regarding ANNOVERA’s side effects can be found at MedlinePlus